Categories: The Charlton Centre

Do you use the government’s Trillium program in addition to your drug plan?

We are very fortunate in the province of Ontario to have many options for supporting the cost of prescription medications.  At Charlton Health we work with specialty medications that have a high cost.  These medications are paid for through patient’s private insurance plans, government-based plans, and drug company support programs. In some cases, patients use a combination of all three types of coverage. We specialize in coordinating this process.

For patients who have a private plan that has a limit to the amount of drug costs it will cover within a year, it may be necessary to use the government-based Trillium Drug Program to help pay the balance of prescription costs. In this situation, the receipt for the portion of the prescription payment not funded by the private plan will now be submitted to the Trillium website rather than being mailed in. This must be submitted by the patient or a member of their household.

For people using Trillium in addition to their private plan, you will be hearing from our team to provide more details on the new process and payment details.

Carolyn Whiskin is the Pharmacy Manager for Charlton Health. Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain, and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Recent Posts

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 week ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

3 weeks ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

1 month ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

2 months ago

World Arthritis and Mental Health Day: October 2025

Every year on October 12, World Arthritis Day raises awareness about the millions of people…

2 months ago

Tremfya: New Dosing Options for Crohn’s Disease and Ulcerative Colitis

Tremfya (guselkumab) has been available for several years to treat plaque psoriasis and psoriatic arthritis.…

3 months ago